Clinical Trials Browser

Interventional × Neurofibromatosis 1 × Sorafenib × Clear all

NCT00727233 2019-12-12

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Phase 1 Completed

Neurofibromatosis 1, Neurofibroma, Plexiform